PG · Q2 2026 Earnings

Cautious

Procter & Gamble

Reported January 22, 2026

30-second summary

30-second take: P&G printed Q2 organic sales growth of exactly 0% (volume -1%, pricing +1%, mix 0%) on revenue of $22.2B (+1% YoY) with core EPS of $1.88 — the softest organic print in years, and right at the floor of the FY26 "in-line to +4%" range management is still defending. GAAP EPS growth guidance was cut from +3–9% to +1–6% on higher restructuring charges, but core EPS, organic sales, and FCF productivity ranges were all reaffirmed, with management leaning on H2 acceleration commentary and a fresh round of "constructive disruption" language from new CEO Jejurikar. The headwind/tailwind composition shifted under the hood — commodities now neutral (vs. ~$100M after-tax headwind previously) and FX tailwind trimmed to ~$200M (from ~$300M), with tariffs (~$400M) and interest/tax (~$250M) unchanged — netting to a $0.19/share fiscal-year EPS headwind that management still disclosed in full.

Headline numbers

EPS

Q2 FY2026

$1.88

Revenue

Q2 FY2026

$22.20B

+1.0% YoY

Gross margin

Q2 FY2026

51.2%

Free cash flow

Q2 FY2026

$3.81B

Operating margin

Q2 FY2026

24.2%

Key financials

Q2 FY2026

Metric	Q2 FY2026	YoY	Q1 FY2026	QoQ
Revenue	$22.20B	+1.0%	$22.40B	-0.9%
EPS	$1.88	—	$1.99	-5.5%
Gross margin	51.2%	—	51.4%	-20bps
Operating margin	24.2%	—	26.2%	-200bps
Free cash flow	$3.81B	—	$4.20B	-9.4%

Guidance

P&G lowered full-year GAAP EPS growth guidance from 3–9% to 1–6% due to higher restructuring charges, while reaffirming core EPS, organic sales, and free cash flow productivity ranges; withdrew detailed headwind/tailwind quantifications.

Guidance is issued for both next quarter and the full year. Both may appear below.

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Diluted EPS growth (GAAP)	FY 2026	3% to 9%	1% to 6%	lowered by 2-3 pts at low end, 3 pts at high end	Lowered
Commodity cost headwind	FY 2026	$100 million after tax	Withdrawn — no replacement	—	Withdrawn
Tariff cost headwind	FY 2026	$400 million after tax	Withdrawn — no replacement	—	Withdrawn
Foreign exchange tailwind	FY 2026	$300 million after tax	Withdrawn — no replacement	—	Withdrawn
Interest expense and tax rate headwind	FY 2026	$250 million after-tax	Withdrawn — no replacement	—	Withdrawn

Reaffirmed unchanged this quarter: Core EPS growth (in-line to up 4%), Organic sales growth (in-line to up 4%), All-in sales growth (1% to 5%), Adjusted free cash flow productivity (85% to 90%), Core effective tax rate (20% to 21%), Capital spending (4% to 5% of fiscal 2026 net sales), Dividend payments (~$10 billion), Share repurchases (~$5 billion)

Segment performance

Q2 FY2026

Segment	Q2 FY2026	YoY
Beauty	$4.039B	+5.0%
Grooming	$1.794B	+2.0%
Health Care	$3.406B	+5.0%
Fabric & Home Care	$7.686B	+1.0%
Baby, Feminine & Family Care	$5.123B	-3.0%

Platform metrics

Q2 FY2026

Segment	Q2 FY2026
Organic Sales Growth	0%
Volume Growth	-1%
Pricing Growth	+1%

Profitability

Q2 FY2026

Segment	Q2 FY2026
Core Gross Margin	51.9%
Core Operating Margin	25.5%
Adjusted Free Cash Flow Productivity	88%
Operating Cash Flow	$5.0B

Other KPIs

Q2 FY2026

Segment	Q2 FY2026
Cash Returned to Shareholders	$4.8B

Management tone

Narrative arc: Q4 "we need a bigger step forward" → Q1 "the teams are on it" → Q2 "we need to invent the CPG company of the future."

The escalation is striking. Two quarters ago management conceded that incremental execution had stopped widening P&G's advantage. Last quarter the language tightened to operational confidence. This quarter, on Jejurikar's first full call as CEO, the framing jumped a level: "We see the landscape around us changing faster than it's ever been in recent memory. Neither we nor our industry in aggregate have adapted as fast as needed." For a company whose institutional voice has historically been steady-state superiority compounding, that sentence is unusually self-critical — and it lands in the same quarter organic growth printed at zero.

Three quarters ago technology integration was discussed as a strategic priority; last quarter it sat inside the restructuring rationale; this quarter it became the operating thesis. Management positioned data, AI-enabled molecular discovery, and integrated capabilities as the lever that will "create a different S-curve for our future growth and value creation." The S-curve language is new and it implies the existing curve is flattening — consistent with the 0% organic print but at odds with the reaffirmed core EPS range.

The hedging on H2 is also worth flagging. Two quarters ago H2 weighting was framed as a calendar mechanic; last quarter as a function of innovation timing; this quarter as dependent on "interventions taking hold" — language that puts a softer floor under the reaffirmation. The anchor quote: "We expect stronger results in the second half, which enables us to maintain fiscal year 2026 guidance ranges across organic sales, core EPS, and adjusted free cash flow productivity." The word "enables" is doing a lot of work in that sentence. If H2 interventions don't deliver, the algorithm doesn't hold.

Recurring themes management leaned on this quarter:

Near-term market softness with confidence in H2 recoveryConstructive disruption and CPG company reinventionIntegration of superior data, technology, and AI capabilities for competitive advantageConsumer-centric brand building with fragmented media reality adaptationSupply chain and retail partnership integration as value creation leversProductivity funding innovation while managing cost headwinds

Risks management surfaced:

Softer consumer markets and aggressive competitionDynamic geopolitical landscapeCommodity cost increases and tariff headwinds (~$500M before tax expected)Significant currency weakness, major supply chain disruptions, or store closuresConsumer inflation impact on value assessment and spending behavior

Q&A highlights

Lauren Lieberman · Barclays

What gives confidence in near-term acceleration mentioned—is it comparisons/base period dynamics or real fundamental improvement? What excites about long-term reinvention of PNG?

Near-term acceleration grounded in real underlying acceleration outside US (Latin America 8%, Europe 3%, China 3%, AMEA 2-4%). US will improve due to absence of Q2 base period headwinds and execution of same innovation/commercial playbook. Long-term excitement stems from growth opportunities in high-growth segments, unique capabilities in data/media/R&D/branding, and ability to leverage technology shifts (AI, retail landscape changes, consumer preferences) to differentiate.

Latin America growth 8%Europe aggregate growth 3%China growth 3% (on top of 5% last quarter)Asia, Middle East, Africa up 2% (4% excluding restructuring exits)

Steve Powers · Deutsche Bank

Where will sequential acceleration manifest most clearly by category/geography? Timeline for putting all transformation pieces together and creating consistent wins across portfolio?

Acceleration expected in family care, baby care, and fem care (benefiting from base period effects). Laundry and fabric enhancers showing strong innovation momentum. Beauty growing 4% globally with skin care upside. 12-18 months needed to get future evenly distributed; some businesses/regions will move ahead of others. Transformation not a single demarcation but uneven rollout.

Family care seeing strong growth in January with share growth emergingBaby care returned to share growth at global levelBeauty growing 4% in aggregateTide boosted described as biggest laundry liquid upgrade in 20 years

Dara Moussinian · Morgan Stanley

What are most important priorities for US execution and re-acceleration? What's changing versus doubling down on existing plans?

Three key changes: (1) Adjust brand building to new media landscape—how people consume content has shifted dramatically; (2) Adjust innovation approach—'stronger core, bigger more' philosophy reflecting retail/e-commerce dynamics; (3) Deliberate focus on consumer value by significantly improving product performance without price increases. Same playbook executed earlier outside US being applied to US market.

Media consumption patterns changed dramatically post-COVID'Stronger core, bigger more' innovation philosophyTide Liquid relaunch as 'stronger core' exampleTide Evo as 'bigger, more' transformational example

Robert Augenstein · Evercore ISI

How is Amazon's disproportionate growth (60-80% of category growth) impacting media efficiency and competitive dynamics? What needs to change? Relevant learnings from China?

Priority is strengthening core brand presentation (landing page visibility, e-content, product performance). Opportunity to innovate at higher price points online where consumer willingness for premium items remains strong. Looking at smaller creator brands for creative inspiration. In India, e-commerce share is 1.8x offline business; being deliberate about winning in fast-growing segments. Drivers include content, item specificity, and right portfolio.

E-commerce growing at ~10x pace of offline in IndiaP&G India e-commerce share 1.8x of offline businessAmazon drives 60-80% of category growth in USPremium pricing opportunities exist online in haircare and skincare

Kevin Grundy · BNP Paribas

Overall assessment of portfolio strategy—is P&G in right segments/TAMs? Are certain businesses less relevant today than in past?

Portfolio strategy focused on daily-use categories where performance matters, aligned with overall strategy. Continuous 'day one look' assessment driving restructuring decisions to exit businesses that are drags or not in future growth areas. Opportunity to strengthen presence in higher-growth segments, including e-commerce and social commerce at premium price points. Health and beauty identified as areas to build greater strength.

Play in daily-use categories where performance matters'Day one look' continuously evaluates portfolio fitExiting businesses identified as drags or non-growth areasOpportunity in higher price points in social commerce

Answers to last quarter's watch list

Q2 organic sales growth and core EPS — Q2 organic sales came in at exactly 0%, validating and sitting below the +1% threshold flagged last quarter. Core EPS of $1.88 was flat versus prior-year Q2, consistent with the reinvestment thesis. The "in-line" floor of the FY26 range is now the operative scenario, not the midpoint.

Resolved negatively

Whether Beauty +6% organic sustains — Beauty organic grew +4% in Q2, landing exactly at the threshold flagged last quarter — not above it. Management cited continued skin care strength and the Olay relaunch, but the inflection has flattened rather than extended. Status: Mixed.

Fabric & Home Care response to Tide Liquid and Tide Evo — F&HC organic was 0% for the second consecutive quarter, with Tide Boosted only reaching full distribution in December. Management said share growth is emerging in family care in January, but the reported segment line has not moved toward the +3% level needed by Q3 to validate the innovation-over-promotion thesis.

Continue monitoring

Discontinuation drag re-quantification — Management reiterated the 30–50 bps FY26 headwind from product and market exits in the transcript. AMEA was cited as +2% reported and +4% ex-restructuring exits, implying the drag is real and material at the regional level. Status: Resolved.

Investment intensity disclosure — No explicit dollar quantification of the reinvestment was disclosed, though Q2 showed 270 bps of gross productivity savings with 220 bps reinvested. The composition is visible in margin bridges but not in standalone dollar terms. Status: Partially resolved.

What to watch into next quarter

Whether Q3 organic sales clears +2% — management's H2 acceleration thesis requires a clear step-up from Q2's 0%. A Q3 print at or below +1% would force a guide cut from the "in-line to +4%" range.

Baby, Feminine & Family Care return to growth — Q2 organic fell -4% YoY; management said baby care has "returned to share growth at a global level" but the revenue line says otherwise. A Q3 print still negative would be the clearest signal that the US intervention narrative is not working.

Fabric & Home Care response to full Tide Boosted distribution — distribution only completed in December, so Q3 is the first clean read. F&HC organic holding at 0% with full distribution would seriously weaken the "biggest innovation cycle in 20 years" framing.

Tariff and FX trajectory — tariffs remain pegged at ~$400M after-tax and FX at ~$200M; either line shifting materially would move the core EPS bridge. Watch for incremental commentary at CAGNY.

Restructuring charge cadence — the GAAP EPS guide cut to +1–6% from +3–9% was attributed to higher restructuring charges. Watch the Q3 10-Q for the explicit restructuring charge run-rate; if charges continue to escalate beyond what was implied in this revised guide, a second GAAP cut becomes likely.

Sources

P&G FY26 Q2 8-K Exhibit 99.1 — earnings press release (SEC): https://www.sec.gov/Archives/edgar/data/80424/000008042426000006/fy2526q2ond8-kexhibit991.htm
P&G Q2 FY26 earnings call — prepared remarks and Q&A

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.